%2C%20Inc./other/PharmaBlock_Sciences_Nanjing_Inc.-logo.png)
PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于2024年上半年提资产减值准备的公告 | 2024-08-16 | Chinese | |
| 华泰联合证券有限责任公司关于南京药石科技股份有限公司部分募集资金投资项目增加实施地点并延期的核查意见 | 2024-08-16 | Chinese | |
| 2024年半年度报告摘要 | 2024-08-16 | Chinese | |
| 董事会决议公告 | 2024-08-16 | Chinese | |
| 南京药石科技股份有限公司舆情管理制度 | 2024-08-16 | Chinese | |
| 2024年半年度报告 | 2024-08-16 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 40022772 | 关于2024年上半年提资产减值准备的公告 | 2024-08-16 | Chinese | ||
| 40022761 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司部分募集资金投资项目增加实施地点并延期的核查意见 | 2024-08-16 | Chinese | ||
| 40022753 | 2024年半年度报告摘要 | 2024-08-16 | Chinese | ||
| 40022745 | 董事会决议公告 | 2024-08-16 | Chinese | ||
| 40022728 | 南京药石科技股份有限公司舆情管理制度 | 2024-08-16 | Chinese | ||
| 40022720 | 2024年半年度报告 | 2024-08-16 | Chinese | ||
| 40022639 | 关于控股股东、实际控制人部分股份质押及解除质押的公告 | 2024-07-16 | Chinese | ||
| 40022632 | 关于调整2022年限制性股票激励计划授予价格的公告 | 2024-07-02 | Chinese | ||
| 40022624 | 关于2024年第二季度可转债转股情况的公告 | 2024-07-02 | Chinese | ||
| 40022615 | 第三届监事会第十九次会议决议公告 | 2024-07-02 | Chinese | ||
| 40022605 | 关于聘任公司常务副总经理的公告 | 2024-07-02 | Chinese | ||
| 40022600 | 第三届董事会第三十四次会议决议公告 | 2024-07-02 | Chinese | ||
| 40022590 | 关于作废2022年限制性股票激励计划部分限制性股票的公告 | 2024-07-02 | Chinese | ||
| 40022577 | 上海君澜律师事务所关于药石科技2022年限制性股票激励计划调整及作废相关事项之法律意见书 | 2024-07-02 | Chinese | ||
| 40022564 | 2022年南京药石科技股份有限公司创业板向不特定对象发行可转换公司债券2024年跟踪评级报告 | 2024-06-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.